New Huntington's drug tested for safety in small trial
NCT ID NCT03787758
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This early-stage study tested the safety and tolerability of an experimental drug called SAGE-718 in 6 people: healthy adults and patients with Huntington's disease. The main goal was to check for side effects and how the drug moves through the body. It was a Phase 1 trial, meaning it focused on safety rather than effectiveness, and results will guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.